Update Breast Cancer 2023 Part 1 – Early Stage Breast Cancer

With abemaciclib (monarchE study) and olaparib (OlympiA study) gaining approval in the adjuvant treatment setting, a significant change in the standard of care for patients with early stage breast cancer has been established for some time now. Accordingly, some diverse developments are slowly being...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartkopf, Andreas D., Fehm, Tanja N., Welslau, Manfred, Müller, Volkmar, Schütz, Florian, Fasching, Peter A., Janni, Wolfgang, Witzel, Isabell, Thomssen, Christoph, Beierlein, Milena, Belleville, Erik, Untch, Michael, Thill, Marc, Tesch, Hans, Ditsch, Nina, Lux, Michael P., Aktas, Bahriye, Banys-Paluchowski, Maggie, Kolberg-Liedtke, Cornelia, Wöckel, Achim, Kolberg, Hans-Christian, Harbeck, Nadia, Stickeler, Elmar, Bartsch, Rupert, Schneeweiss, Andreas, Ettl, Johannes, Würstlein, Rachel, Krug, David, Taran, Florin-Andrei, Lüftner, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617391/
https://www.ncbi.nlm.nih.gov/pubmed/37916183
http://dx.doi.org/10.1055/a-2074-0551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617391/
https://www.ncbi.nlm.nih.gov/pubmed/37916183
http://dx.doi.org/10.1055/a-2074-0551

Ejemplares similares